Improving lipid management in patients with acute coronary syndrome: The ACS Lipid EuroPath tool
Alessandro Sionís, José Luis Zamorano(Hospital Universitario Ramón y Cajal), Dariusz Dudek(Jagiellonian University), Azfar Zaman(Royal Stoke University Hospital), J. Wouter Jukema(Leiden University Medical Center), Angela Pirillo(Ospedale Bassini), Ulf Landmesser(Deutsches Herzzentrum der Charité), Alberico L. Catapano(University of Milan), Gaetano Maria De Ferrari(University of Pavia), François Schiele(Hôpital Saint-Jacques)
Cited by 14
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k